Linoleyl carnitine
Based on 1 Customer Validation
Linoleyl carnitine is an acylcarnitine and metabolite. Linoleyl carnitine in the liver is negatively correlated with pantothenic acid and citric acid in serum. Linoleyl carnitine accumulates in mitochondrial CPT II deficiency.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.94%
- CAS 番号: 36816-10-1
- 分子式: C25H45NO4
- 分子量:423.63
-
保管条件:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Endogenous Metabolite アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
IC50 & Target
[1]|
CPT-2 |
Human Endogenous Metabolite |
体外実験
Linoleyl carnitine in the liver is negatively correlated with pantothenic acid and citric acid in serum. Linoleyl carnitine accumulates in mitochondrial CPT II deficiency[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 36816-10-1
-
性状 Solid
-
分子量 423.63
-
分子式 C25H45NO4
-
Color White to yellow
-
SMILES
CCCCC/C=C\C/C=C\CCCCCCCC(O[C@H](CC([O-])=O)C[N+](C)(C)C)=O
-
Structure Classification
-
Initial Source
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
溶剤 & 溶解度
体外:
DMSO : 100 mg/mL (236.06 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (264 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
取扱説明書 (2659 KB)
参考文献
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.3606 mL | 11.8028 mL | 23.6055 mL | 59.0138 mL |
| 5 mM | 0.4721 mL | 2.3606 mL | 4.7211 mL | 11.8028 mL | |
| 10 mM | 0.2361 mL | 1.1803 mL | 2.3606 mL | 5.9014 mL | |
| 15 mM | 0.1574 mL | 0.7869 mL | 1.5737 mL | 3.9343 mL | |
| 20 mM | 0.1180 mL | 0.5901 mL | 1.1803 mL | 2.9507 mL | |
| 25 mM | 0.0944 mL | 0.4721 mL | 0.9442 mL | 2.3606 mL | |
| 30 mM | 0.0787 mL | 0.3934 mL | 0.7869 mL | 1.9671 mL | |
| 40 mM | 0.0590 mL | 0.2951 mL | 0.5901 mL | 1.4753 mL | |
| 50 mM | 0.0472 mL | 0.2361 mL | 0.4721 mL | 1.1803 mL | |
| 60 mM | 0.0393 mL | 0.1967 mL | 0.3934 mL | 0.9836 mL | |
| 80 mM | 0.0295 mL | 0.1475 mL | 0.2951 mL | 0.7377 mL | |
| 100 mM | 0.0236 mL | 0.1180 mL | 0.2361 mL | 0.5901 mL |
Keywords
- Linoleyl carnitine
- 36816-10-1
- Carnitine Palmitoyltransferase (CPT)
- Endogenous Metabolite
- carnitine palmitoyltransferase II
- lipid metabolism
- long-chain fatty acid
- male Wistar rats
- mitochondrial matrix transport
- metabolic disturbance
- oxidative stress
- rat liver tissue
- acrylamide-induced hepatotoxicity
- acylcarnitine
- Inhibitor
- inhibitor
- inhibit